K. Fritzen

Patient-Centred Care in Type 2 Diabetes Mellitus - Key Aspects of PDM-ProValue are reflected in the 2018 ADA/EASD Consensus Report.

O. Schnell, K. Fritzen, C. Stautner, 2019, Diabetes research and clinical practice.

Modeling of Diabetes and Its Clinical Impact

L. Heinemann, O. Schnell, K. Fritzen, 2018, Journal of diabetes science and technology.

PDM-ProValue meets cardiovascular outcome trials in diabetes

O. Schnell, K. Fritzen, 2019, Cardiovascular Diabetology.

Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System

O. Schnell, K. Fritzen, M. Hummel, 2018, Journal of diabetes science and technology.

Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator—Comparison of Five European Healthcare Systems

A. Nicolucci, B. Vergès, O. Schnell, 2020, Journal of Diabetes Science and Technology.

Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management

A. Nicolucci, B. Vergès, O. Schnell, 2019, Journal of diabetes science and technology.

The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

D. Owens, O. Schnell, B. Guerci, 2020, Diabetes research and clinical practice.

COVID-19 and Cardiovascular Comorbidities.

N. Marx, D. Müller-Wieland, O. Schnell, 2020, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Potential Cost Savings for the Healthcare System of the Russian Federation Through the Utilization of a Blood Glucose Meter With Color Range Indicator

O. Schnell, K. Fritzen, L. Popovich, 2020, Journal of diabetes science and technology.